查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2008726

非处方人工泪液市场报告：按产品类型、容器类型、配方、应用、分销管道和地区划分（2026-2034 年）

OTC Artificial Tears Market Report by Product, Container Type, Formulation, Application, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球非处方（OTC）人工泪液市场规模达57亿美元。 IMARC集团预测，到2034年，该市场规模将达到82亿美元，2026年至2034年的复合年增长率为4.05%。

非处方（OTC）人工泪液是一种用于润滑眼睛、缓解眼痛、不适、灼热感、发红、畏光和刺激感的眼药水。其主要成分包括聚葡萄糖、甘油、丙二醇、羟丙基甲基纤维素（HPMC）和羧甲基纤维素。人工泪液广泛用于治疗干眼症，干眼症是指结膜、角膜或整个眼球表面无法获得足够的水分或润滑。非处方人工泪液具有良好的生物相容性，有助于稳定泪膜、促进癒合并抑制泪液蒸发。此外，非处方人工泪液有多种剂型，例如软膏、喷雾剂、乳剂、溶液和凝胶，使用非常方便。

非处方人工泪液市场趋势：

老年人口的不断增长，尤其是易患慢性眼科疾病的老年人口，是推动市场成长的主要因素之一。干眼症、糖尿病和营养不良的盛行率不断上升，导致人们对能够快速缓解眼睛不适的非处方人工泪液的需求增加。此外，智慧型手机、电视和笔记型电脑等电子设备的广泛使用，导致萤幕使用时间过长和眼睛疲劳，也对非处方人工泪液的普及产生了积极影响。各种产品创新，例如开发出眨眼激活涂层的产品，正在促进市场成长。这些涂层能够为蒸发性干眼症患者提供保湿效果。这些产品与隐形眼镜的广泛联合使用，能够促进角膜供氧并防止眼表干燥，也推动了市场成长。其他因素，特别是都市区日益严重的空气污染和公众健康意识的提高，预计也将推动市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球非处方人工泪液市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 解决方案
  • 软膏
  • 乳液
  • 凝胶
  • 喷雾溶液
  • 暂停

第七章 市场区隔：依货柜类型

  • 塑胶单剂量容器
  • 用于多剂量给药的塑胶容器
  • 其他的

第八章 市场区隔：依配方划分

  • 含防腐剂
  • 不含防腐剂型

第九章 市场区隔：依应用领域划分

  • 干眼症
  • 过敏
  • 感染疾病
  • 紫外线和蓝光防护
  • 隐形眼镜的保湿性能
  • 其他的

第十章 市场区隔：依分销通路划分

  • 医院药房
  • 药局和零售药房
  • 网路药房

第十一章 市场区隔：按地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十二章 SWOT 分析

第十三章：价值链分析

第十四章：波特五力分析

第十五章：价格分析

第十六章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • AbbVie Inc.
    • Alcon
    • Bausch and Lamb
    • Jawa Pharmaceuticals Pvt. Ltd.
    • OASIS Medical, Inc.
    • OcuSoft
    • Rohto Eye Drops
    • Scope Ophthalmics Ltd.
    • Sentiss Pharma Pvt. Ltd.
    • Thea Pharmaceuticals Limited
    • Ursapharm Arzneimittel GmbH
Product Code: SR112026A4958

The global OTC artificial tears market size reached USD 5.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.05% during 2026-2034.

Over the Counter (OTC) artificial tears are eye drops that are used for lubricating eyes and providing relief from pain, discomfort, burning, redness, photophobia and irritation in the eyes. They are manufactured using dextran, glycerin, propylene glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Artificial tears are widely used for the treatment of dry eyes, which is a medical condition when sufficient moisture or lubrication is not generated on the conjunctiva, cornea or entire surface of the eye. OTC artificial tears are biocompatible and aid in stabilizing the tear film, promoting healing and minimizing tear evaporation. In addition to this, OTC artificial tears are also available in ointment, spray, emulsion, solution and gel forms that are highly convenient use.

OTC ARTIFICIAL TEARS MARKET TRENDS:

The rising geriatric population that is prone to chronic eye-related disorders is one of the key factors driving the growth of the market. Due to the increasing prevalence of dry eye syndrome (DES), diabetes and nutritional deficiencies, there is a rising demand for OTC artificial tears to provide immediate relief from discomfort in the eyes. Additionally, the increasing utilization of electronics, such as smartphones, televisions (TVs) and laptops, leading to excessive screen time and eye fatigue, is positively impacting the adoption of OTC artificial tears. Various product innovations, such as the development of variants fortified with blink-activated coatings, are providing a thrust to the market growth. These coatings provide ocular hydration to patients suffering from evaporative dry eye syndrome. In line with this, the widespread product adoption with contact lenses to facilitate the flow of oxygen to the cornea and prevent dryness on the surface of the eyes is favoring the market growth. Other factors, including rising levels of pollution, especially in the urban regions, along with the increasing health consciousness among the masses, are anticipated to drive the market toward growth.

KEY MARKET SEGMENTATION:

Breakup by Product:

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray Solution
  • Suspensions

Breakup by Container Type:

  • Plastic Single Dose Container
  • Plastic Multi-Dose Container
  • Others

Breakup by Formulation:

  • Preservative Based
  • Non-Preservative Based

Breakup by Application:

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV and Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Drug Store and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global OTC artificial tears market with detailed profiles of all major companies, including:

  • AbbVie Inc.
  • Alcon
  • Bausch and Lamb
  • Jawa Pharmaceuticals Pvt. Ltd.
  • OASIS Medical, Inc.
  • OcuSoft
  • Rohto Eye Drops
  • Scope Ophthalmics Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • Thea Pharmaceuticals Limited
  • Ursapharm Arzneimittel GmbH

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global OTC artificial tears market in 2025?

2. What is the expected growth rate of the global OTC artificial tears market during 2026-2034?

3. What are the key factors driving the global OTC artificial tears market?

4. What has been the impact of COVID-19 on the global OTC artificial tears market?

5. What is the breakup of the global OTC artificial tears market based on the product?

6. What is the breakup of the global OTC artificial tears market based on the container type?

7. What is the breakup of the global OTC artificial tears market based on formulation?

8. What is the breakup of the global OTC artificial tears market based on the application?

9. What is the breakup of the global OTC artificial tears market based on the distribution channel?

10. What are the key regions in the global OTC artificial tears market?

11. Who are the key players/companies in the global OTC artificial tears market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global OTC Artificial Tears Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Solution
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Ointment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Emulsion
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gel
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Spray Solution
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Suspensions
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Container Type

  • 7.1 Plastic Single Dose Container
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plastic Multi-Dose Container
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Formulation

  • 8.1 Preservative Based
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Preservative Based
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Dry Eye Syndrome
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Allergies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Infections
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 UV and Blue Light Protection
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Contact Lens Moisture Retention
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Drug Store and Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AbbVie Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Alcon
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Bausch and Lamb
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Jawa Pharmaceuticals Pvt. Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 OASIS Medical, Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 OcuSoft
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Rohto Eye Drops
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Scope Ophthalmics Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Sentiss Pharma Pvt. Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Thea Pharmaceuticals Limited
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Ursapharm Arzneimittel GmbH
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: OTC Artificial Tears Market: Major Drivers and Challenges
  • Figure 2: Global: OTC Artificial Tears Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: OTC Artificial Tears Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: OTC Artificial Tears Market: Breakup by Product (in %), 2025
  • Figure 5: Global: OTC Artificial Tears Market: Breakup by Container Type (in %), 2025
  • Figure 6: Global: OTC Artificial Tears Market: Breakup by Formulation (in %), 2025
  • Figure 7: Global: OTC Artificial Tears Market: Breakup by Application (in %), 2025
  • Figure 8: Global: OTC Artificial Tears Market: Breakup by Distribution Channel (in %), 2025
  • Figure 9: Global: OTC Artificial Tears Market: Breakup by Region (in %), 2025
  • Figure 10: Global: OTC Artificial Tears (Solution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: OTC Artificial Tears (Solution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: OTC Artificial Tears (Ointment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: OTC Artificial Tears (Ointment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: OTC Artificial Tears (Emulsion) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: OTC Artificial Tears (Emulsion) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: OTC Artificial Tears (Gel) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: OTC Artificial Tears (Gel) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: OTC Artificial Tears (Spray Solution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: OTC Artificial Tears (Spray Solution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: OTC Artificial Tears (Suspensions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: OTC Artificial Tears (Suspensions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: OTC Artificial Tears (Plastic Single Dose Container) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: OTC Artificial Tears (Plastic Single Dose Container) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: OTC Artificial Tears (Plastic Multi-Dose Container) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: OTC Artificial Tears (Plastic Multi-Dose Container) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: OTC Artificial Tears (Other Container Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: OTC Artificial Tears (Other Container Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: OTC Artificial Tears (Preservative Based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: OTC Artificial Tears (Preservative Based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: OTC Artificial Tears (Non-Preservative Based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: OTC Artificial Tears (Non-Preservative Based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: OTC Artificial Tears (Dry Eye Syndrome) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: OTC Artificial Tears (Dry Eye Syndrome) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: OTC Artificial Tears (Allergies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: OTC Artificial Tears (Allergies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: OTC Artificial Tears (Infections) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: OTC Artificial Tears (Infections) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: OTC Artificial Tears (UV and Blue Light Protection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: OTC Artificial Tears (UV and Blue Light Protection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: OTC Artificial Tears (Contact Lens Moisture Retention) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: OTC Artificial Tears (Contact Lens Moisture Retention) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: OTC Artificial Tears (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: OTC Artificial Tears (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: OTC Artificial Tears (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: OTC Artificial Tears (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: OTC Artificial Tears (Drug Store and Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: OTC Artificial Tears (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: OTC Artificial Tears (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: OTC Artificial Tears (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: North America: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: North America: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United States: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United States: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Canada: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Canada: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Asia-Pacific: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Asia-Pacific: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: China: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: China: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Japan: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Japan: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: India: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: India: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: South Korea: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: South Korea: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Australia: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Australia: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Indonesia: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Indonesia: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Europe: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Europe: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Germany: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Germany: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: France: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: France: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: United Kingdom: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: United Kingdom: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Italy: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Italy: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Spain: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Spain: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Russia: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Russia: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Latin America: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Latin America: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Brazil: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Brazil: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Mexico: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Mexico: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Others: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Middle East and Africa: OTC Artificial Tears Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Middle East and Africa: OTC Artificial Tears Market: Breakup by Country (in %), 2025
  • Figure 98: Middle East and Africa: OTC Artificial Tears Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Global: OTC Artificial Tears Industry: SWOT Analysis
  • Figure 100: Global: OTC Artificial Tears Industry: Value Chain Analysis
  • Figure 101: Global: OTC Artificial Tears Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: OTC Artificial Tears Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: OTC Artificial Tears Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: OTC Artificial Tears Market Forecast: Breakup by Container Type (in Million USD), 2026-2034
  • Table 4: Global: OTC Artificial Tears Market Forecast: Breakup by Formulation (in Million USD), 2026-2034
  • Table 5: Global: OTC Artificial Tears Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: OTC Artificial Tears Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 7: Global: OTC Artificial Tears Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: OTC Artificial Tears Market: Competitive Structure
  • Table 9: Global: OTC Artificial Tears Market: Key Players